Literature DB >> 10728410

Peri-operative myocardial tissue injury and the release of inflammatory mediators in coronary artery bypass graft patients.

E J Fransen1, J G Maessen, W T Hermens, J F Glatz, W A Buurman.   

Abstract

OBJECTIVE: This study was conducted to evaluate to what extent the ischemia-reperfusion injury resulting from the cardiopulmonary bypass (CPB) and aortic cross-clamping procedures during coronary artery bypass grafting (CABG) contributes to the systemic inflammatory response generally found in these patients.
METHODS: Serum levels of enzymes (CK and CK-MB) and non-enzymatic proteins (FABP and myoglobin) as markers of myocardial tissue injury, bactericidal permeability increasing protein (BPI) as an indicator of neutrophil activation, interleukin-6 (IL-6) as inducer of the acute phase response and lipopolysaccharide binding protein (LBP) as parameter of the acute phase response were measured in 15 low-risk CABG patients with cardiopulmonary bypass (CPB), and 17 low-risk CABG patients without CPB.
RESULTS: Already 0.5 h after reperfusion significantly increased plasma levels of all markers of myocardial tissue injury were noted in patients having surgery with CPB, but not in non-CPB patients. No significant differences were found between both groups for BPI and IL-6 levels in the early reperfusion period. BPI and IL-6 levels were higher in the non-CPB group on the first post-operative day (P < 0.05). However, no correlations were found for any marker of peri-operative tissue damage with either early neutrophil activation, or acute phase reactants.
CONCLUSIONS: Perioperative myocardial injury resulting from CPB and aortic cross-clamping in low-risk CABG patients does not contribute to the release of inflammatory mediators in these patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10728410     DOI: 10.1016/s0008-6363(99)00403-4

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  6 in total

1.  Change in stroke volume in response to fluid challenge: assessment using esophageal Doppler.

Authors:  Margareta Roeck; Stephan M Jakob; Thomas Boehlen; Lukas Brander; Rafael Knuesel; Jukka Takala
Journal:  Intensive Care Med       Date:  2003-04-09       Impact factor: 17.440

2.  Protective effect of silymarin during coronary artery bypass grafting surgery.

Authors:  Tagreed Altaei
Journal:  Exp Clin Cardiol       Date:  2012

3.  Ischemia-modified albumin use as a prognostic factor in coronary bypass surgery.

Authors:  Muhip Kanko; Sadan Yavuz; Can Duman; Tulay Hosten; Emin Oner; Turan Berki
Journal:  J Cardiothorac Surg       Date:  2012-01-05       Impact factor: 1.637

4.  Influence of dextran-70 on systemic inflammatory response and myocardial ischaemia-reperfusion following cardiac operations.

Authors:  Károly Gombocz; Agnes Beledi; Nasri Alotti; Gábor Kecskés; Valéria Gábor; Lajos Bogár; Tamás Koszegi; János Garai
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

5.  Preoperative serum h-FABP concentration is associated with postoperative incidence of acute kidney injury in patients undergoing cardiac surgery.

Authors:  Mehmet Oezkur; Armin Gorski; Jennifer Peltz; Martin Wagner; Maria Lazariotou; Christoph Schimmer; Peter U Heuschmann; Rainer G Leyh
Journal:  BMC Cardiovasc Disord       Date:  2014-09-12       Impact factor: 2.298

6.  Anti-inflammatory effects of propofol during cardiopulmonary bypass: a pilot study.

Authors:  A Samir; N Gandreti; M Madhere; A Khan; M Brown; V Loomba
Journal:  Ann Card Anaesth       Date:  2015 Oct-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.